Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 139 Results Clear All
Colleagues look back on Warner Greene's 40 year career
Gladstone Experts History HIV/AIDS Virology Greene Lab
Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab
San Francisco Chronicle—Although requirements for mask wearing and social distancing have eased around the country, a third winter of the pandemic is looming. Gladstone Senior Investigator Warner Greene recommends paying attention to local trends in case numbers to decide which COVID-19 precautions to take.
Gladstone Experts COVID-19 Virology Greene Lab
San Francisco Chronicle—In an update to a previous article, Senior Investigator Warner Greene now expects both COVID and flu to spread during the holidays and encourages people in high-risk groups to take extra precautions to avoid infection.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, shares his views on the likelihood of a new COVID surge this winter.
Gladstone Experts COVID-19 Virology Greene Lab
Invisishield Technologies—Gladstone Senior Investigator Warner Greene has been appointed President and Chief Scientific Officer of Invisihield Technologies. Invisishield is focused on developing intranasal preventatives for respiratory viruses, including SARS-CoV-2.
Gladstone Experts COVID-19 Virology Greene Lab
Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.
Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, says that it makes more sense to boost immunity with the newly approved bivalent vaccines targeting Omicron than with vaccines that aim at long-extinct variants of the coronavirus.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab
ABC7 News—The federal government plans to roll out a new vaccine against the BA.5 Omicron variant now predominant in the US early this fall. Senior Investigator Warner Greene, MD, PhD, says that you might want to hold off for your next booster shot until you can get this new vaccine, which will offer better protection against currently circulating variants.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab
San Francisco Chronicle—A year has passed since California dropped most public health restrictions related to COVID-19, but the pandemic isn’t over. Senior Investigator Warner Greene notes that the virus is still spreading effectively, and people can be infected repeatedly with different subvariants.
Gladstone Experts COVID-19 Virology Greene Lab
ABC News—Gladstone virologists investigated the effect of the Omicron variant on the immune response. Melanie Ott describes her team’s discovery that previous infection with Omicron does not result in strong immunity to other known SARS-CoV-2 variants. However, as Nadia Roan explains, individuals who were vaccinated before becoming infected with Omicron did have a broadly protective immune response, emphasizing the importance of the vaccines in saving lives.
Gladstone Experts COVID-19 Virology Doudna Lab Greene Lab Ott Lab Roan Lab
ABC News—COVID-19 case numbers are rising in the San Francisco Bay Area, driven by sublineages of the Omicron variant. Gladstone virologist Warner Greene explains that the new subvariants are more infectious, and can evade the antibodies produced in response to vaccination and previous infection.
Gladstone Experts COVID-19 Virology Greene Lab
KCBS News—Although Omicron and related new variants can infect vaccinated people, Senior Investigator Warner Greene says vaccines still protect us well against severe disease, and urges people to get at least one booster shot.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
ABC News—The FDA recently announced that they would authorize a second COVID-19 vaccine booster shot for people 50 and older, and those 12 and older who are immunocompromised. Senior Investigator Warner Greene explains that the second booster can protect people who don’t have vigorous immune systems from infection, and predicts that it may be more broadly recommended for all adults in the months to come.
Gladstone Experts COVID-19 Virology Greene Lab
ABC News—A sub-variant of Omicron known as BA.2 is causing a spike in COVID-19 cases in Europe, and is predicted to become the globally dominant variant in the coming weeks. However, Senior Investigator Warner Greene says that vaccinated and boosted individuals are still well protected against serious illness, and spread of this new variant is unlikely to lead to new lockdowns.
Gladstone Experts COVID-19 Virology Greene Lab
